EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2026 0.4073
June 30, 2026 0.4792
March 31, 2026 0.373
December 31, 2025 0.2213
September 30, 2025 0.0141
June 30, 2025 0.0063
March 31, 2025 -0.0444
December 31, 2024 -0.3802
September 30, 2024 -0.6847
June 30, 2024 -0.6236
March 31, 2024 -0.5655
December 31, 2023 -0.3129
September 30, 2023 0.0633
June 30, 2023 -0.0151
March 31, 2023 -0.8921
December 31, 2022 -0.8609
September 30, 2022 -0.875
June 30, 2022 -0.8856
March 31, 2022 0.0101
December 31, 2021 0.0689
September 30, 2021 0.091
June 30, 2021 0.0586
March 31, 2021 -0.1184
December 31, 2020 0.6149
September 30, 2020 0.4171
Date Value
June 30, 2020 -1.549
March 31, 2020 -1.600
December 31, 2019 -2.752
September 30, 2019 -2.603
June 30, 2019 -0.5217
March 31, 2019 -0.54
December 31, 2018 -0.165
September 30, 2018 -4.276
June 30, 2018 -4.330
March 31, 2018 -4.18
December 31, 2017 -5.555
September 30, 2017 -5.285
June 30, 2017 -7.799
March 31, 2017 -7.837
December 31, 2016 -6.609
September 30, 2016 -2.539
June 30, 2016 0.466
March 31, 2016 0.4773
December 31, 2015 0.5328
September 30, 2015 0.3745
June 30, 2015 0.1057
March 31, 2015 0.6324
December 31, 2014 0.8142
September 30, 2014 0.6725
June 30, 2014 0.4473

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
TG Therapeutics, Inc. 2.746
Pfizer Inc. 0.6992
Liquidia Corp. 1.364
Johnson & Johnson 6.592
Eli Lilly & Co. 30.44